Jacob Thaysen
Directeur Général chez ILLUMINA, INC.
Fortune : 5 M $ au 30/04/2024
Profil
Jacob Thaysen is the founder of Cantion A.
He is currently the Chief Executive Officer & Director at Illumina, Inc. and also serves as a Director at Lasergen, Inc. Previously, he was the SVP & President-Life Sciences & Applied Markets at Agilent Technologies, Inc. from 2018 to 2023.
He also held positions as a Director at Gen9, Inc., Vice President-Research & Development at Cytologix Corp., and Vice President-System Development, R&D at Dako Denmark ApS.
Thaysen received his graduate and doctorate degrees from the Technical University of Denmark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ILLUMINA, INC.
0,03% | 05/03/2024 | 44 563 ( 0,03% ) | 5 M $ | 30/04/2024 |
Postes actifs de Jacob Thaysen
| Sociétés | Poste | Début |
|---|---|---|
| ILLUMINA, INC. | Directeur Général | 25/09/2023 |
Lasergen, Inc.
 Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Lasergen, Inc. operates as a biotechnology company which focuses on commercializing novel chemistry for life science solutions. The firm specializes in lightning terminators, next generation sequencing, and next generation histology. The company was founded by Michael L. Metzker in 2002 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jacob Thaysen
| Sociétés | Poste | Fin |
|---|---|---|
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 05/09/2023 |
Cytologix Corp.
 Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Directeur Technique/Scientifique/R&D | 18/05/2011 |
Cantion A/S
 Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Cantion A/S manufactures measuring, testing, navigation, and control equipment. The firm engages in research, development and production of components or products based in whole or in part on nanotechnology, as well as related service and consulting services. The company was founded on February 1, 2006 and is headquartered in Aalbord, Denmark. | Fondateur | - |
Gen9, Inc.
 Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Directeur Technique/Scientifique/R&D | - |
Formation de Jacob Thaysen
| Technical University of Denmark | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AGILENT TECHNOLOGIES, INC. | Health Technology |
| ILLUMINA, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Cytologix Corp.
Cytologix Corp. Miscellaneous Commercial ServicesCommercial Services The number of people suffering from cancer is constantly growing. A key factor in ensuring patients the best treatment is to make an accurate and full diagnosis and choose the right form of treatment at an early stage. At Dako it builds its business to constantly improve cancer diagnostics. The pathology lab is where all cancer related diagnoses are being prepared and where they have its main focus. By focusing on the entire workflow of the pathology labs worldwide they believe that they can contribute in improving quality, safety and cost efficiency for the benefit of the doctors, the lab and especially the patients waiting for results. The strategic focus of Dako is centered on workflow in the pathology laboratory with the aim of: 1. Reducing time from biopsy to diagnosis 2. Improving quality and reliability of the diagnosis 3. Reducing laboratory costs. The company goal is to help its customers help their patients the most human way possible. They work closely with doctors and experts in the field of cancer diagnostics to ensure they stay at the forefront of their needs and the market development. Partnering is a way for to get access to relevant technologies outside its own core competencies. They aim to be an attractive partner and employer and have a highly trained and skilled international staff to develop, manufacture and market its products all over the world. Its organization is spread world wide. They stay in close relations and support openness and dialogue as an important element in the way they work. Dako is a global business with headquarters in Denmark. It was founded by the Danish medical doctor Niels Harboe in 1966 and has more than 40 years' experience in the development and production of reagents and antibodies. | Commercial Services |
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Health Technology |
Cantion A/S
Cantion A/S Electronic Equipment/InstrumentsElectronic Technology Cantion A/S manufactures measuring, testing, navigation, and control equipment. The firm engages in research, development and production of components or products based in whole or in part on nanotechnology, as well as related service and consulting services. The company was founded on February 1, 2006 and is headquartered in Aalbord, Denmark. | Electronic Technology |
Lasergen, Inc.
Lasergen, Inc. Electronic Equipment/InstrumentsElectronic Technology Lasergen, Inc. operates as a biotechnology company which focuses on commercializing novel chemistry for life science solutions. The firm specializes in lightning terminators, next generation sequencing, and next generation histology. The company was founded by Michael L. Metzker in 2002 and is headquartered in Houston, TX. | Electronic Technology |
